In patients with encephalitis caused by antibodies against LGI1/CASPR2, in addition to the trend for mRS improvement with ivMP + PE + IVIG compared to ivMP monotherapy, there was also a hint of mRS improvement with the application of maintenance therapy involving rituximab or cyclophosphamide and the treatment of an existing neoplasm. This evidence concerns the gene CNTNAP2 and encephalitis.